RI Records Potential Transactions Of Health Products Of IDR 11.96 Billion In SeaCare Malaysia

JAKARTA - Indonesia managed to record a potential transaction of IDR 11.96 billion in the Southeast Asia Healthcare and Pharma Show 2025 (SEACARE 2025).

This achievement shows that Indonesian health products are increasingly gaining a place in the international market.

The SEACare 2025 is an international exhibition of health products that include health care, medicines, and medical devices. The exhibition was held by the Malaysian National Cancer Society, MMA Public Health Society NCD Malaysia, and Frost and Sullivan.

The exhibition will take place from 23 to 25 April 2025 at the International Trade and Exhibition Center (Mitec), Kuala Lumpur, Malaysia.

Kuala Lumpur Trade Attache Aziza Rahmaniar Salam conveyed that Indonesia's participation is expected to increase the diversification of export products.

Aziza said that this participation is also expected to strengthen Indonesia's position as a strategic partner in providing health products in the region.

"The participation in the 2025 SEACare is a real step for the government in encouraging Indonesian products to appear in the global market. The achievement of transaction potential of IDR 11.96 billion shows that Indonesia's health products are competitive and are increasingly gaining a place in the international market," said Aziza in an official statement, Thursday, May 22.

At this exhibition, the Indonesian Pavilion featured, among others, medical equipment, medical equipment, health care products, medicines, and supplements. There are four companies participating, namely Mensa Group, PT Graha Teknomedika, the Indonesian Medical Device Manufacturers Association (ASPAKI), and the Indonesian Medical Ecosystem Development Association (Hipelki).

The ASPAKI representative said that participating in the SEACare 2025 exhibition in Kuala Lumpur had a positive impact in expanding export market access for Indonesian medical device manufacturers.

Various superior products were introduced to potential partners and buyers from Malaysia as well as other Southeast Asian countries.

Business actors who are members of ASPAKI also benefit from direct promotions, opening new networks, and the potential for long-term export cooperation.

Meanwhile, representatives of the Mensa Group explained that SEACare 2025 is an exhibition in the pharmaceutical sector that offers more than just a showroom through seminars, product demonstrations, panel discussions, and meetings between business actors (B2B).

At this exhibition, participants also gained valuable knowledge and had the opportunity to establish strategic opportunities for innovation and market expansion in various countries.